Nouvelles Eulerpool Psycheceutical Bioscience

Eulerpool-AFX Psycheceutical Bioscience

Psycheceutical Bioscience Actualités des actions

Psycheceutical Bioscience est surveillé par de nombreux journalistes et investisseurs du monde entier. Nous regroupons ici les dernières actualités Psycheceutical Bioscience.

• 16 mai ·

  Yahoo
  Historical Regulatory Filing Deficiences Continue to Stifle Psycheceutical Biosciences
• 17 janvier ·

  Yahoo
  Psycheceutical Bioscience Strategically Pivots Into the Brain-Computer Interface (BCI) Space
• 12 décembre ·

  Yahoo
  Dr. Neilank Jha Appointed as Executive Chairman and Chief Executive Officer of Psycheceutical Bioscience Inc.
• 1 novembre ·

  Yahoo
  Psycheceutical Bioscience Launches Wefunder Crowdfunding Campaign for Safer Psychedelic Dosing
• 10 août ·

  Yahoo
  Psycheceutical Announces Successful First Cohort Dosing; Moves to Dose Escalation in Phase I Trial of NeuroDirect Ketamine for PTSD
• 1 août ·

  Yahoo
  Psycheceutical Bioscience Announces Completion of PCAOB Audit and Future Corporation Action Strategy
• 13 juillet ·

  Yahoo
  First Patient Dosed in Psycheceutical's Phase I Study Exploring Topical Administration of Ketamine to Treat PTSD
• 18 avril ·

  Yahoo
  The Next Generation Of Mental Health Treatment: Psycheceutical Bioscience Inc.’s (OTCPK:BWVI) Novel Topical Ketamine Delivery
• 13 avril ·

  Yahoo
  Psycheceutical Bioscience, Inc. Named a 2023 Top 10 Biotech Startup by Life Sciences Review
• 9 avril ·

  Nasdaq
  Weekly Preview: Earnings to Watch This Week 4-9-23 (C, DAL, JPM, TLRY)